دورية أكاديمية

Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system

التفاصيل البيبلوغرافية
العنوان: Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system
المؤلفون: Caurio, Cássia F.B., Allende, Odelta S., Kist, Roger, Vasconcellos, Izadora C.S., Rozales, Francieli P., Reck-Kortmann, Maikel, Dalla Lana, Daiane F., Alegretti, Ana Paula, Neto, Giácomo B., Pasqualotto, Alessandro C.
المصدر: Brazilian Journal of Infectious Diseases. June 2020 24(3)
بيانات النشر: Brazilian Society of Infectious Diseases, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Cytomegalovirus, qPCR, In-house assay, Standardization, 1st WHO International Standard for Human Cytomegalovirus, Cost-minimization analysis
الوصف: Introduction: Cytomegalovirus may cause severe disease in immunocompromised patients. Nowadays, quantitative polymerase chain reaction is the gold-standard for both diagnosis and monitoring of cytomegalovirus infection. Most of these assays use cytomegalovirus automated molecular kits which are expensive and therefore not an option for small laboratories, particularly in the developing world. Objective: This study aimed to optimize and validate an in-house cytomegalovirus quantitative polymerase chain reaction test calibrated using the World Health Organization Standards, and to perform a cost-minimization analysis, in comparison to a commercial cytomegalovirus quantitative polymerase chain reaction test. Study design: The methodology consisted of determining: optimization, analytical sensitivity, analytical specificity, precision, curve variability analysis, and inter-laboratorial reproducibility. Patients (n = 30) with known results for cytomegalovirus tested with m2000 RealTime System (Abbott Laboratories, BR) were tested with the in-house assay, as well as patients infected with other human herpes virus, in addition to BK virus. A cost-minimization analysis was performed, from a perspective of the laboratory, assuming diagnostic equivalence of the methodologies applied in the study. Results: The in-house assay had a limit of detection and quantification of 60.3 IU/mL, with no cross-reactivity with the other viral agents tested. Moreover, the test was precise and had a R 2 of 0.954 when compared with the m2000 equipment. The cost analysis showed that the assay was economically advantageous costing a median value of 37.8% and 82.2% in comparison to the molecular test in use at the hospital and the m2000 equipment, respectively. Conclusions: These results demonstrated that in-house quantitative polymerase chain reaction testing is an attractive alternative in comparison to automated molecular platforms, being considerably less expensive and as efficacious as the commercial methods.
نوع الوثيقة: article
وصف الملف: text/html
اللغة: English
تدمد: 1413-8670
DOI: 10.1016/j.bjid.2020.04.015
URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000300191
حقوق: info:eu-repo/semantics/openAccess
رقم الأكسشن: edssci.S1413.86702020000300191
قاعدة البيانات: SciELO
الوصف
تدمد:14138670
DOI:10.1016/j.bjid.2020.04.015